Reducing how often patients receive immune checkpoint inhibitors can dramatically reduce medical costs while allowing patients to remain on lifesaving drugs, according to a recent study from Fred ...

Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today highlighted newly published independent preclinical research evaluating the effects of PV-10 in a clinically ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Yep, a new Scientific Reports study found that endurance exercise (think: long ...

Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune ...

How does the same infection, say the flu or a cold, give some people mild symptoms and leave others suffering? Why do people develop autoimmune diseases? And will we ever be able to predict when—and ...

Inherited variations in antibody genes can affect how we respond to infections and vaccines, show two new studies from ...